By using this site, you agree to our Privacy Policy and our Terms of Use. Close

It seems no further efforts will be made to eliminate the virus here, keeping it low, preparing for a second wave and living with Sars-Cov-2 until a successful vaccine is readily available. Which could be a while:

https://www.ctvnews.ca/health/coronavirus/full-coronavirus-vaccine-unlikely-by-next-year-expert-1.5021224

PARIS -- There is little chance of a 100-per cent effective coronavirus vaccine by 2021, a French expert warned Sunday, urging people to take social distancing measures more seriously. "A vaccine is several years in development," said epidemiologist Arnaud Fontanet, a member of the team of scientists advising the government on the crisis, speaking on BFMTV television. "Of course, there is an unprecedented effort to develop a vaccine, but I would be very surprised if we had that was effective in 2021," he added.

The rest of 2020 is going to suck, likely into summer next year :/ Home schooling alternated with going to school (alternating weekly or 2 days one week, 3 days the other) is what the next school year is going to look like. Only Norway and New Zealand seem to have gotten rid of it next to some smaller nations.

Most business will be back open on Friday, still over 100 new cases daily in phase 2, the ones that go in to get tested. At least the border closure has been extended for another month, to August 21st.
https://www.ctvnews.ca/politics/canada-u-s-agree-to-keep-borders-closed-another-30-days-sources-1.5023287

Not all that closed though, again 2 Americans fined for violating the quarantine act
https://northernontario.ctvnews.ca/two-floridians-fined-for-violating-the-quarantine-act-in-northeastern-ontario-1.5023603



The Cannabis study made some progress
https://www.ctvnews.ca/health/coronavirus/are-new-cannabis-strains-key-to-fighting-covid-19-these-alta-researchers-think-so-1.5018962

So far, they have found about a dozen that are able to “substantially decrease the expression of the ACE2 receptor, the one that is required by the virus to enter our cells,” he told CTV’s Your Morning Friday.

Two or three strains developed in the Kovalchuks’ lab and tested on human tissue models can decrease that receptor’s acceptance of the virus – essentially closing the door to infection – by 75 per cent or more, said Igor Kovalchuk. That gives the body a much better chance of fighting the viral invader.

Strains the scientists are working with are cannabidiol (CBD)-predominant. That means they have high presence of the medicinal ingredient of cannabis and relatively little of the tetrahydrocannabinol (THC), which is the psychoactive component of cannabis that causes a high.

The next big step is real-world testing of the cannabis strains that have performed well in the lab, says Olga Kovalchuk. “Right now, what’s most important for us is to actually find partnerships and develop clinical trials.”

The researchers have not tested smoking cannabis and say none of the strains they are studying are available for sale at local cannabis shops.